This Scientist Discovers Why Some Animals Age in 2 Years While Others Live 500. His $1M Bet Says Someone Alive Will Hit 150

Evolution’s approach to aging seems counterintuitive at first glance.

Some animals live mere years while others cruise past the century mark.

In a recent podcast episode, Dr. Steven Austad, a pioneering aging researcher with decades of experience, shared fascinating insights about longevity science and what might help humans reach 150 years old.

His journey from Hollywood lion tamer to leading gerontologist reveals unconventional wisdom about extending human healthspan.

From Lion Tamer to Longevity Scientist

Dr. Austad’s path into aging research began with an unexpected discovery in South America. While studying opossums during a postdoctoral project, he noticed something shocking about these cat-sized marsupials.

They aged as rapidly as mice, despite their larger size.

I just assumed they would, you know, live 10 or 15 years like a house cat. That it captured my interest immediately.

This observation sparked a career-defining question: How could evolution produce animals that age at such dramatically different rates?

Why Some Animals Age Faster Than Others

The answer lies not in lifespan itself, but in reproductive patterns. Animals living in hazardous environments face constant predation pressure, which shapes their entire life strategy.

Opossums exemplify this perfectly—roughly 80% die from predators in nature.

It’s the reproductive pattern that is selected for. But a consequence of becoming an adult rapidly and breeding very rapidly is that you age rapidly as well.

Dr. Austad tested this hypothesis by comparing mainland opossums with island populations lacking predators. After 5,000 years of isolation, island opossums lived 25% longer than their mainland cousins.

Conversely, animals in safer environments—like bowhead whales living over 200 years or Greenland sharks approaching 500—develop remarkably slow aging processes.

The Bold Bet: Someone Alive Today Will Reach 150

Twenty-five years ago, Dr. Austad made a provocative wager with colleague Jay Olshansky. His claim? At least one person alive in 2000 would celebrate their 150th birthday by 2150.

The stakes remain high despite no one approaching Jeanne Calment’s record of 122 years since her death.

150 only one person has to live to be 150 years old. It’s not like every you know, life expectancy has to reach that. And that’s only about 20% longer than Jeanne Calment lived.

Laboratory research provides reason for optimism. Scientists routinely extend animal lifespans by 20% or more using various interventions.

Crucially, some therapies work even when started late in life—the mouse equivalent of age 70 in humans.

Most Promising Longevity Interventions

GLP-1 Drugs Lead the Pack

Among current pharmaceutical candidates, GLP-1 receptor agonists show exceptional promise according to Dr. Austad.

These medications, originally developed for diabetes and weight management, demonstrate effects extending beyond metabolic health. New versions with fewer side effects continue emerging.

Rapamycin: Robust but Complex

Rapamycin produces the most consistent life-extension effects across experimental animals by inhibiting the mTOR pathway. However, recent research reveals complications.

Studies in flies show diet dramatically influences outcomes—rapamycin extended life on one diet but shortened it on another.

The drug also compromises muscle building, creating potential trade-offs for aging humans who desperately need muscle preservation.

Metformin: Affordable with Questions

Dr. Austad appreciates metformin primarily because promising data comes from humans rather than mice. The planned TAME trial could provide definitive answers.

The thing that Metformin has going for it that I really like is that it’s off-patent, it’s inexpensive and if it turned out that it really prolonged health, almost everybody could afford to be taking it.

Still, most existing evidence involves diabetic or pre-diabetic patients. Whether healthy individuals would benefit remains unclear.

The Laboratory Mouse Problem

A fundamental flaw plagues aging research: scientists study animals that fail spectacularly at resisting aging.

Lab mice, worms, and flies all age rapidly compared to their body size. This creates a critical question about translating findings to humans, who already excel at longevity.

Just because we’re capable of making a mouse that lives 2 years live 3 years, that doesn’t necessarily mean that we’re going to be able to use the same approach to make people who live 80 years live, let’s say, 120 years.

Wild mice demonstrate the stark difference. When researchers test lab mice strength by having them hang from wires, wild mice simply pull themselves up and run across.

Lab mice possess immune systems resembling newborns because sterile housing protects them from microbial exposure for generations.

Supplements: Skepticism Warranted

Dr. Austad expresses strong doubts about popular longevity supplements making bold claims without solid evidence.

• Resveratrol: Already proven ineffective
• NAD boosters: Latest research suggests NAD doesn’t even decline with age
• Most others: Lack rigorous clinical evidence

I’m skeptical about any of the ones that are making claims now. Most of the evidence are from personal testimonials, and that’s the weakest kind of evidence one can imagine.

His reasoning? Truly effective compounds would pursue FDA approval to command premium pricing rather than existing as unregulated supplements.

Combination Therapy: The Future Approach

Single interventions face inherent limitations because aging affects multiple systems simultaneously. Every drug creates trade-offs.

Rapamycin and metformin both harm muscle—disastrous for older adults needing strength to prevent falls and maintain mobility.

Future protocols will likely combine pharmaceutical interventions with optimized lifestyle factors. One drug might protect brain health while another safeguards kidney function from the first drug’s side effects.

Personalization matters tremendously. The “omics” revolution—genomics, proteomics, metabolomics—enables tailoring interventions to individual biology rather than applying one-size-fits-all solutions.

Lifestyle Still Reigns Supreme

No pharmaceutical breakthrough eliminates the need for foundational health practices. Exercise provides benefits unlikely to be fully replicated by any pill.

Blue Zones—regions where people routinely reach their 90s and beyond—demonstrate the power of lifestyle factors:

• Strong social connections
• Regular physical activity integrated into daily life
• Mental stimulation and purpose
• Moderate, whole-food nutrition

Dr. Austad personally wishes he’d prioritized diet earlier in his career rather than relying on convenient fast food during busy work periods.

The Protein and mTOR Dilemma

Younger individuals can likely maintain muscle despite moderate protein restriction. Their reserves provide buffer against temporary deficits, especially with regular strength training.

Older adults face different calculations. Muscle preservation becomes paramount for preventing falls, maintaining independence, and avoiding frailty.

Low-protein diet is going to be tough to maintain muscle, which, you know, for young people, they have enough excess muscle that it’s not going to matter, particularly if people are working out a lot.

Calorie restriction faces similar challenges. While extending animal lifespans in laboratory settings, it weakens bones and muscles—catastrophic consequences in real-world environments where falls prove deadly.

Time-Restricted Eating Replaces Calorie Restriction

The traditional calorie restriction paradigm attracts few adherents because sustained 20-30% caloric reduction proves psychologically unbearable for most people.

Time-restricted eating offers practical alternatives. Limiting food consumption to specific windows—say, 10 AM to 6 PM—proves far more sustainable.

Members of the Calorie Restriction Society illustrate the challenge. Despite their dedication, they constantly remind each other to exercise more because muscle wasting concerns them.

Yet they resist because working out increases hunger, conflicting with their primary goal.

Biomarkers: The Key to Rapid Progress

Waiting decades to determine if interventions extend human lifespan would cripple progress. Reliable biomarkers could assess efficacy within two years instead of twenty-five.

Emerging biomarker categories include:

• Epigenetic clocks: DNA methylation patterns predicting biological age
• Proteomic profiles: Blood protein signatures indicating organ-specific aging
• Metabolomic markers: Small molecule patterns reflecting cellular health

Imagine discovering your heart ages like a 30-year-old’s while your liver resembles an 80-year-old’s. Targeted interventions could address specific vulnerable systems.

If we can tell in 2 years that this thing is really helping and it’s not having bad side effects, that would be tremendous.

Artificial Intelligence Accelerates Discovery

AI promises to revolutionize drug discovery by screening thousands of compounds simultaneously. Traditional laboratory testing of each candidate would require centuries.

Computational simulations could model how interventions affect different biological systems, predicting outcomes before expensive clinical trials begin.

The risk? Overlooking critical variables that simulations fail to capture, leading to unexpected real-world failures.

Independent verification remains essential. Richard Feynman’s warning echoes through Dr. Austad’s approach: “The easiest person to fool is yourself.”

Why Billionaires Aren’t Taking Rapamycin Yet

Jeff Bezos invests billions in Altos Labs. Larry Ellison funds anti-aging research generously. Yet neither appears to be personally experimenting with rapamycin or similar compounds.

Dr. Austad understands their caution—he wouldn’t take rapamycin at this stage either.

I can see why he wouldn’t jump into try rapamycin. I want to wait until there’s evidence. And when there’s evidence, then I’d be happy to take rapamycin or GLP-1s or anything else that showed real benefits.

Recent evidence that late-life interventions still provide substantial benefits reduces urgency. Starting therapies at age 50 or 60 might prove nearly as effective as beginning at 30.

The Longevity Escape Velocity Question

Some futurists propose “longevity escape velocity”—the point where medical advances add more than one year of life expectancy per calendar year.

This creates a theoretical path to indefinite lifespan extension.

Dr. Austad assigns this scenario 0.00001% probability—essentially zero. Fundamental biological constraints likely prevent such outcomes regardless of technological progress.

This probability assessment has lifestyle implications. Someone believing escape velocity imminent might sacrifice decades of enjoyment as an “ultimate marshmallow test.”

But if the probability approaches zero, such sacrifice becomes pointless.

The Real Goal: Healthspan, Not Just Lifespan

Current medicine extends lifespan by keeping people alive who would have previously died—but often in poor health.

Data shows healthy longevity in the United States hasn’t improved since 2000 despite rising life expectancy. People live longer but spend more years managing chronic diseases and disabilities.

We’re living longer, but we’re not living in such good health longer. That’s not a good trend. We need to reverse that trend.

Japan provides an instructive contrast. Japanese citizens enjoy the highest life expectancy globally, the most centenarians per capita, and the lowest healthcare burden for elderly populations.

Traditional Medicine Won’t Reach 150

Better cancer treatments, earlier disease detection, and improved cardiovascular interventions won’t achieve 150-year lifespans.

These approaches address diseases individually rather than targeting aging itself—the root cause generating most age-related pathology.

Winning Dr. Austad’s bet requires genuinely slowing biological aging, not just managing its consequences more effectively.

Laboratory evidence proves this goal achievable in principle. Multiple interventions reliably slow aging across diverse species.

Gene Editing: Promise and Peril

DNA editing technologies remain in rudimentary stages compared to pharmaceutical approaches. The field looks interesting but carries substantially greater risks than even experimental drugs like rapamycin.

Unintended consequences loom large when permanently altering genetic code. Cost poses another barrier—gene therapies currently dwarf even expensive GLP-1 medications.

Development timelines suggest other interventions will reach clinical application first.

What About Sleep and Social Connection?

Multiple lifestyle factors contribute to healthy longevity. No single element trumps all others—exercise, nutrition, sleep, and social relationships all matter tremendously.

Sleep presents unique challenges. Everyone recognizes its importance, but older adults struggle to achieve quality sleep naturally.

Drug-induced sleep appears less beneficial than natural rest, yet improving natural sleep proves difficult.

Social connections and mental stimulation show powerful effects across populations. Blue Zone inhabitants maintain active social lives and sense of purpose well into advanced age.

The Balance Between Longevity and Living

Dr. Austad observed Calorie Restriction Society members spending so much energy optimizing longevity that they forgot to actually live.

I think that’s something we want to also be aware of. I mean life is to be enjoyed, right? If life isn’t enjoyable then what’s the point?

Sustainable approaches integrate health optimization with genuine enjoyment. Extreme restriction that eliminates pleasure defeats the purpose of extended longevity.

Nobody knows how many healthy years remain available. Sacrificing decades of fulfillment for uncertain future payoffs represents questionable strategy.

The science continues advancing rapidly. Tools unavailable even ten years ago now enable discoveries impossible in previous eras.

Whether someone alive today celebrates their 150th birthday remains uncertain. But the combination of pharmaceutical innovation, lifestyle optimization, and personalized medicine offers genuine hope for extending healthy human lifespan beyond current limits.